Call for Abstracts

On behalf of Organizing Committee of the Society for Medical Decision Making 44th Annual North American Meeting, we would like to thank you for submitting your work as an abstract.

The on-line submission and evaluation process is administered by Kenes M+, the meeting organizing secretariat. Please take a moment to read the below guidelines before proceeding to submit your abstract.

Extended Abstract Submission Deadline is
Monday, June 6, 2022 at 11:59 PM PST

ABSTRACT SUBMISSION IS CLOSED NOW!

 
Please take a moment to read the below guidelines before submitting your abstract:

ABSTRACT SUBMISSION GUIDELINE

General Rules for All Submissions:

  1. All abstracts must be written in English.
  2. All abstracts must be submitted on-line through the abstract submission system by June 6, 2022, by 23:59 PST. Abstracts that are sent via e-mail will not be included in the abstract assessment process.
  3. Abstracts should report original work that:
    - has not been published or accepted for publication in manuscript form prior to abstract submission.
    - has not been previously presented at a national or international scientific meeting, including an SMDM European, Asia-Pacific or North American Conference.
    - is not identical to a previously published abstract.
  4. Abstracts may reflect a similar body of research to that published or presented in any of the above categories but should include new aspects of work (i.e., findings, results, analyses, or interpretation).

Authorship Guidelines:

  1. Each abstract presenter must disclose his or her source of financial support. This information is required by the University of Alabama at Birmingham, the Continuing Medical Education provider for the Annual SMDM Meeting. This information will not affect the scientific review of the abstract.
  2. SMDM welcomes an unlimited number of abstract submissions per presenter. However, a maximum of 2 abstracts will be accepted per presenter.
  3. The presenting author of accepted abstract must register for and attend the Annual Meeting. Author(s) are responsible for expenses associated with the submission and presentation of an abstract.
  4. Authors or co-authors from policy organizations, patient advocacy groups, and industry/pharmaceutical companies are eligible to submit abstracts.
  5. The submitting and presenting authors are required to ensure that all co-authors are aware of the content of the abstract before the submission.
  6. Accepted abstracts of presenting authors who have paid their registration fees by the abstract registration deadline, August 31, 2022 will be included in the final Scientific Program and published as submitted in the online version of the Society’s peer-reviewed journal, Medical Decision Making, on the SMDM website and at the Annual Meeting.
  7. Always make sure to check the final abstract with the system's preview function before submission and edit as necessary. It is the author's responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific content will be reproduced as typed by the author.

ABSTRACT CONTENT CATEGORIES

Scientific abstracts are welcomed in a wide range of topics relevant to medical decision making. For review and scheduling purposes, submitted abstracts will be grouped in the following categories. Authors will be required to select the appropriate category for their abstract upon submission.

Category

Relevant Topics Include:

Decision Psychology and Shared Decision Making (DEC)

Risk communication; Risk perception; Doctor-patient communication; Decision support; Decision aids; Patient empowerment; Health behaviors and education; Medical education

Applied Health Economics (AHE)

Cost analyses; Cost-effectiveness analyses; Health economics; Pharmacoeconomics

Health Services, Outcomes and Policy Research (HSOP)

Administrative database and outcomes research; Applied modeling analyses; Clinical strategies and guidelines; Comparative effectiveness research; Ethical, legal and social issues; Global health research; Health policy; Health services research; Health technology assessment

Quantitative Methods and Theoretical Developments (QMTD)

Bayesian methods and analyses; Advances in simulation and decision modeling; Model calibration/validation; Decision theory

Patient and Stakeholder Preferences and Engagement (PSPE)

Stated-preferences methods (including discrete choice experiments, conjoint analysis, best-worst scaling, contingent valuation); Qualitative, mixed methods and quantitative studies exploring the priorities and preferences of patients and other stakeholders; Patient and stakeholder engagement in research; Utility and health state valuation

 

LEE B. LUSTED STUDENT PRIZE COMPETITION

The Lee B. Lusted Student Prize Competition recognizes the top presentations by students or trainees at the Annual Meeting and provides students and trainees an additional opportunity to share their research and receive feedback from senior researchers in the field. Each year, two awards are given in each of the five scientific areas of interest (AHE, DEC, HSOP, PSPE, QTMD). Students and trainees are required to indicate their desire to be considered for this competition when the abstract is submitted and provide the name and contact information for a sponsor who can verify and attest their candidacy as a student/trainee.

Abstracts must meet the following criteria to be eligible for the Lee B. Lusted Student Prize Competition:

  1. The student or trainee must be the first author and the presenting author.
  2. The student or trainee must have played a substantive role in the submitted abstract, including the conception and implementation of the research project.
  3. The student or trainee must have been enrolled in an educational program leading to a degree or certificate at the time the research was done. Examples of qualifying educational programs include professional school, residency, fellowship, or programs leading to degrees such as PhD, MS, MBA, MD, RN, PharmD etc. The status as a student at the time the research was done must be verified by a sponsor, such as a faculty mentor or program official. The sponsor will be contacted by the SMDM office and asked to confirm the eligibility of the abstract for the student prize competition.
  4. If accepted, the student or trainee must register for the annual meeting and present the abstract.

Note: All submitted abstracts, whether or not they are accepted as finalists in the Student Prize Competition, remain in consideration for presentation in the general scientific sessions.

Abstracts accepted for the Lusted Student Prize Competition will be presented as poster presentations.  The Lusted finalists will also be required to attend a poster session during the conference. Additional presentation details will be provided upon your confirmation as a Lusted finalist.

ABSTRACT FORMAT & PREPARATION

  • Category: A main category from the list above that best represents your abstract must be selected during Step 1 of the submission process.
  • Preferred presentation types: One of the below presentation options can be selected.
    • Oral presentation
    • Poster presentation
    • No preference
  • Institution(s): The institution(s) of the authors should be indicated fully with the "department" and "institution" names while avoiding any abbreviations such as Dept., Inst., Hosp., etc. Please include the City and Country for each institution. (For US, please make sure to enter the country information after the state name.)

Do not include titles, degrees, institutional appointments, street names, or postal codes.
Enter each affiliation only once: i.e., if there are 5 authors and 3 of whom are from same affiliation and 2 of whom are from another, you will have 2 institutions, NOT 5. However, if there are 2 or more departments at the same institution represented, they can be entered separately.
If any of the authors have more than one affiliation, enter both affiliations in a compounded style as one affiliation: i.e., if there are 5 authors and 2 of whom are from same affiliation (Institute A), 2 of whom are from another (Institute B), and 1 of whom is from both affiliations (Institutes A and B), you will have 3 institutions, NOT 5 or NOT 2. (First institution: Institute A, second one: Institute B and the third one: Institute A & Institute B). Include the City and Country for each affiliation.

  • Author(s):First, middle and last names of all the authors must be fully indicated correctly and in the right order. Please pay attention to match the institutions to the right authors, and make sure that you select the “presenting author” correctly.
  • Presenting Author Information: Please enter the presenting author’s contact information.
  • Abstract Title:Abstract title can contain a maximum of 150 characters. Should be brief and should clearly indicate the content of the paper. Abbreviations may not be used in abstract titles.
  • Abstract Body: 375 word maximum, excluding title and author information.
    Organization of the body of the abstract as follows:
    - Purpose of the study, preferably one sentence.
    - Methods used to conduct the research in sufficient detail to evaluate their appropriateness and novelty.
    - Results, stated in sufficient detail to support conclusions. It is not satisfactory to state “Results will be discussed” or “Data will be presented.”
    - Conclusions
  • Keywords: Minimum 1 keyword is required, and maximum 6 keywords can be entered. All keywords should be separated with commas.
  • Tables and Figures: A simple table, graph, or figure may be included. The image will be scaled from its original size so the abstract will fit into its allotted space. 
  • Conflict of Interest: Presenting author must declare if he/she have any conflict of interests in their abstract with selecting Yes/No option.
  • Please do not submit multiple copies of the same abstract.
  • Please note your username and password for future use. If you forget this information, please get in contact with the Meeting Organizing Secretariat at (mrodic@kenes.com). 
  • Changes to submitted abstracts will not be accepted after the submission deadline, 11:59 PM PST, Monday, May 23 2022.

Please ensure that the e-mail address of presenting author is entered correctly to enable the Meeting Organizing Secretariat to communicate the presenting author regarding the abstract. All information regarding the acceptance, any required adjustments, and scheduling will be communicated via e-mail to the abstract’s presenting author.

When the submission process is finalized, you will see your abstract under the heading "Submitted Abstracts". If your abstract is not seen there, please kindly turn back and check the steps of your submission. Please be aware that the Scientific Committee will not receive "Not-Submitted Abstracts" and these therefore CANNOT be taken into consideration in the abstract evaluation process.

Upon submitting of your abstract an e-mail including the "Abstract Number" and "Abstract Title" will be sent to the submitting author.

EVALUATION PROCESS AND ACCEPTANCE LETTERS

All submitted abstracts will be reviewed by the Scientific Review Committee.

Only those accepted will be invited to present at the Meeting. You will receive notification confirming whether or not your abstract has been accepted by early August, 2022.

The abstract presenting author must be registered for the meeting at the latest by August 31, 2022.

Abstracts of unregistered presenting authors who do not complete the registration payment by this deadline will be removed from the final program and will not be published in the Society’s peer-reviewed journal, Medical Decision Making.

 

 

 

Organised By

Kenes Group, Office: Kenes M+